Thyroid dose assessments due to inhalation of 131I for nuclear medicine workers
- PMID: 36544792
- PMCID: PMC9760871
- DOI: 10.3389/fpubh.2022.1027782
Thyroid dose assessments due to inhalation of 131I for nuclear medicine workers
Abstract
Background: In general, medical staff who work in nuclear medicine should be entirely safe in their professional environment. Nevertheless, we already know that the working environment of the nuclear medicine staff is not completely safe due to the handling of high amounts of radionuclides for diagnostic and therapy applications, which is especially relevant for 131I (as a non-sealed source).
Purpose: The goal of this study was to assess the inhaled 131I thyroid dose in nuclear medicine workers and to introduce a simple method for internal exposure monitoring.
Methods: Using 2-IN*2-in NaI (Tl) scintillation spectrometer and its supporting software (InSpector Maintenance Utility and Genie 2000), from 2019 to 2021, internal thyroid irradiation monitoring, an internal thyroid irradiation monitoring investi A NaI (Tl) scintillation spectrometer and its sugation was carried out for 3 consecutive years, between 2019 and 2021, in staff members of nuclear medicine departments engaged with iodine therapy.
Results: 131I activity was found highest in the thyroid of nuclear medicine workers involved with the manual packaging and delivery of the radioisotope, while it was not detected in staff members involved with the automatic packaging and drug delivery. The activity range was found to be 30.00 ± 6.60-6070.00 ± 1335.40 Bq for the exposed personnel, and the estimated dose was 0.05-6.77 mSv. In 2021, three workers had an annual equivalent dose above 5 mSv.
Conclusion: By monitoring the thyroid 131I in staff members of the nuclear medicine department, it was found that there are 131I internal occupational exposure risks. The best solution is automatic packaging and drug delivery.
Keywords: 131I; internal doses; nuclear medicine; radiation protection; thyroid.
Copyright © 2022 Liu, Li, Zhang, Zhang, Liu, Wu, Niu and Zhang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Euroatom European Atomic Energy Community . Directive 2013/59/Euratom protection against ionising radiation. Off J Eur Union. (2014) 57. Available online at: http://data.europa.eu/eli/dir/2013/59/2014-01-17
-
- Garin E, Laffont S, Rolland Y, Olivie D, Lecloirec J, Herry JY, et al. . Safe radiation exposure of medical personnel by using simple methods of radioprotection while administrating 131-I-lipiodol therapy for hepatocellular carcinoma. Nucl Med Commun. (2003) 24:671–8. 10.1097/00006231-200306000-00009 - DOI - PubMed
-
- ICRP International Commission of Radiological Protection . Limits for intakes of radionuclides by workers. Part ICRP Publication 30. In: Ann ICRP. (1979). Pergamon: Oxford. p. 2.
-
- ICRP International Commission of Radiological Protection . The human respiratory tract model for radiological protection. ICRP Publication 66. In: Ann ICRP. (1994). Pergamon, Oxford. p. 24. - PubMed
-
- ICRP International Commission of Radiological Protection . The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. In: Ann ICRP. (2007). Pergamon, Oxford. p. 37. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
